Related Experiment Video

Updated: Aug 14, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Effects of rapid increase of phenylalanine intake in older PKU children

A S Beckner, W R Centerwall, L Holt

    Journal of the American Dietetic Association
    |August 1, 1976
    PubMed

    Insights

    Children transitioned from strict low-phenylalanine diets to moderate-protein diets showed normal growth. Phenylalanine intake and serum levels fluctuated, with some children exceeding safe limits, potentially linked to behavioral issues.

    Area of Science:

    • Biochemistry
    • Pediatrics
    • Metabolic Disorders

    Background:

    • Children with metabolic disorders often require specialized diets.
    • Phenylketonuria management typically involves strict phenylalanine restriction.
    • Transitioning dietary protocols requires careful monitoring.

    Purpose of the Study:

    • To evaluate the effects of transitioning from low-phenylalanine diets to moderate-protein diets in children.
    • To monitor phenylalanine intake, serum levels, and associated clinical parameters.
    • To assess growth, activity, irritability, and intelligence during the dietary change.

    Main Methods:

    • Twelve children previously on strict low-phenylalanine diets were switched to a moderate-protein diet over five weeks.
    • Observations were conducted by parents, teachers, and clinical teams.
    • Periodic evaluations included dietary phenylalanine intake, serum phenylalanine levels, activity, irritability, growth, and intelligence assessments.

    Main Results:

    • All children exhibited normal growth patterns for their age.
    • Dietary phenylalanine intake increased significantly initially, then fluctuated.
    • Serum phenylalanine levels mirrored dietary intake; nine children maintained levels at or below 20 mg/100 ml, while three exceeded this threshold, with one experiencing behavioral problems and weight gain.

    Conclusions:

    • Transitioning to a moderate-protein diet can lead to fluctuating phenylalanine levels in previously restricted children.
    • Close monitoring of serum phenylalanine is crucial, as elevated levels may correlate with adverse outcomes.
    • Individual responses to dietary changes vary, necessitating personalized management strategies.

    More Related Videos

    Quantitative Autoradiographic Method for Determination of Regional Rates of Cerebral Protein Synthesis In Vivo11:01

    Quantitative Autoradiographic Method for Determination of Regional Rates of Cerebral Protein Synthesis In Vivo

    Published on: June 28, 2019

    Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans09:18

    Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

    Published on: September 7, 2021

    Related Concept Videos

    Overview of Protein Metabolism01:21

    Overview of Protein Metabolism

    Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
    Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
    Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

    Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

    The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
    A study on guinea pigs examined the...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...